Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-794-4902
Are you Dr. Ahmed?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sairah Ahmed, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Alabama, and Arizona.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
University of ConnecticutResidency, Internal Medicine, 2003 - 2006
Khyber Medical CollegeClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2011 - 2027
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
OK State Medical License 2020 - 2026- OK State Medical License 2020 - 2026
TN State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.Dai Chihara, Raphael E Steiner, Ranjit Nair, Lei Feng, Sairah Ahmed
Blood Advances. 2025-04-08 - Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.Yago Nieto, Jeremy Ramdial, Benigno Valdez, Peter F Thall, Roland Bassett
Clinical Cancer Research. 2025-03-17 - Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With ...Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, Elaine E Cha, Alison K Yoder
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15
Press Mentions
Need CAR T Cell Therapy? Here’s What to ExpectJanuary 20th, 2023- What Are the New Weight Loss Drugs Everyone Is Talking About & What’s the Connection Between Weight and Cancer?January 15th, 2023
- Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin LymphomaDecember 13th, 2022
- Join now to see all
